Program

PRELIMINARY PROGRAM
 

Day 1 - Wednesday, 27 May

 
 9:00 Opening of the Meeting 
 9:05 

Ghosn Jade, 2018
Andrea De Luca Lecture: 
The Top 10 Important Observations of the Last Year Affecting Clinical Management
Jade Ghosn, MD, PhD - Bichat University Hospital, France

 
    
 Session 1:  Challenges in Central and Eastern Europe
 
 9:35

Noori,Teymur 2018
Epidemiology of HIV and Hepatitis in CEE
Teymur Noori - European Centre for Disease Prevention and Control (ECDC), Sweden

 
 10:00

Streinu Cercel, Anca 2017

Transmitted and Acquired Resistance: Special Populations
Anca Streinu - Cercel, MD, PhD - National Institute of Infectious Diseases "Prof. Dr. Matei Bals", Romania 

 
 10:25Gender neutral avatar 120x160
HIV and Tuberculosis in CEE 
Francis Drobniewski, PhD - Imperial College London, UK
 
 10:50Scaling-Up Integration of TB, HIV, and Viral Hepatitis Testing in Europe 
 11:15 Discussion 
    
 11:30Coffee Break 
    
 Industry-Sponsored Symposium
 
 12:00Symposium 
    
 13:00Lunch 
    
 Session 2: Patient-Reported Outcomes and Studies
 
 14:00

Introductory Lecture
Martin Duracinsky, MD, PhD - Paris Diderot University, France

 
 14:25Discussion 
    
                   Abstract-Driven Presentations
 
 14:50 4 slots 
    
 15:50 Coffee Break 
    
 Session 3: Clinical Management of HIV: Abstract-Driven Presentations
 
 16:20

When to Start: Test and Treat
Roger Paredes, MD, PhD - Irsi Caixa Foundation, Spain

 
 16:45 
Clinical Case
Romain Palich, MD - Pitié - Salpêtrière Hospital, France
 
    
 17:10Best of Posters 
 17:30Guided Poster Tour 1 
    
  Welcome Reception and Poster Viewing 
    
 

Day 2 - Thursday, 28 May

 
 Session 4: What's in the Pipeline? Presentations from Scientists in the Industry
 
 8:30Philadelphia Literacy
Kathleen Squires, MD
 
Global Director Scientific Affairs - ID/HIV, Merck, USA
 
 8:45Hanneke Schuitemaker,2019 120x160
Hanneke Schuitemaker, PhD

Vice President, Head Viral Vaccine Discovery and Translational Medicine, Janssen, The Netherlands
 
 9:00


Kirsten White, MD, PhD

Senior Director, Clinical Virology, Gilead Sciences, USA

 
 9:15


Michael Aboud, MBChB

Global Franchise Medical Head, ViiV Healthcare, UK

 
 9:30


Antoine Deslandes, PharmD, PhD

Scientific Advisor - Translational Medicine and Early Development, Sanofi, France

 
    
 9:45Discussion 
    
 10:15Coffee Break and Poster Viewing 
  Guided Poster Tour 2 
    
 Industry-Sponsored Symposium 
 
 11:15 Symposium 
    
 12:15Lunch 
    
 Session 5: Resistance to Long-Acting Antivirals
 
 13:15

Resistance to Long-Acting Antivirals
Anne-Geneviève Marcelin, PharmD, PhD - Sorbonne Université, France

 
 13:45 


Pro-Con Debate: Long-Acting Therapy is for Patients with Poor/Good Adherence
Charles Flexner, MD - Johns Hopkins University School of Medicine, USA

 
    
                   Abstract-Driven Presentations
 
 14:153 slots 
    
 15:00Coffee Break 
    
 Session 6: Management of Viral Hepatitis
 
 15:30

Treatment of Hepatitis B for HIV Clinicians
Anna Maria Geretti, MD, PhD - University of Liverpool, UK

 
 16:00Hepatitis C Resistance: Pro-Con Debate 
  

JM Pawlotsky, MD, PhD - University of Paris-Est, France

 
  

Francesca Ceccherini - Silberstein, PhDUniversity of Rome “Tor Vergata”, Italy

 
 16:30

Re-Infection and Retreatment: Challenges and Approaches
Karine Lacombe, MD, PhD - Hôpital Saint Antoine Paris, France

 
    
                   Abstract-Driven Presentations 
 17:002 slots 
    
 17:30Guided Poster Tour 3 
 18:00End of Program Day 2 
    
 19:00 Group Dinner in Le Train Bleu Restaurant (pre-registration required) 
 

Day 3 - Friday, 29 May

 
 Session 7: PrEP and Resistance
 
 8:30

Gender neutral avatar 120x160
Overview Lecture
Constance Delaugerre, MD - Hopital Saint Louis, France

 
 9:00 Round Table Discussion: Challenges to Widespread PrEP in Europe 
  

Clinical Aspects
Milosz Parczewski, MD, PhD - Pomeranian Medical University, Poland

 
  

  Meulbroek, Michael 2019
Social Aspects
Michael Meulbroek - BCN Checkpoint, Spain

 
  

Financial Aspects
Yazdan Yazdanpanah, MD, PhDBichat Claude-Bernard Hospital, France

 
     
                   Abstract-Driven Presentations
 
 10:00 2 slots 
    
 10:30Coffee Break 
    
 Session 8: Vaccine Development / Immune Modulation
 
 11:00

Gender neutral avatar 120x160
Clinical Trials on Vaccines / Vaccine as Prevention and Vaccine as Treatment
Beatriz Mothe Pujadas, MD - IrsiCaixa Foundation, Spain

 
 11:30


TLR Agonists
Ole Søgaard, MD, PhD - Aarhus University Hospital, Denmark

 
 12:00

Schwartz, Olivier 2020

bnABs
Olivier Schwartz, PhD - Institut Pasteur, France

 
 12:30
Reservoirs and DNA sequencing
Mathias Lichterfeld, MD, PhD - Harvard University Center for AIDS Research, USA 
 
    
 13:00Closure of the Workshop and Ricardo Camacho Awards